Cargando…
New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
Cases of endometrial cancer have increased in recent years, but the prognosis of patients with this disease has also been improved by combined modality therapy with surgery, radiotherapy and chemotherapy. However, the development of new therapy is required from the perspectives of conservation of fe...
Autores principales: | UMENE, KIYOKO, BANNO, KOUJI, KISU, IORI, YANOKURA, MEGUMI, NOGAMI, YUYA, TSUJI, KOSUKE, MASUDA, KENTA, UEKI, ARISA, KOBAYASHI, YUSUKE, YAMAGAMI, WATARU, TOMINAGA, EIICHIRO, SUSUMU, NOBUYUKI, AOKI, DAISUKE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597537/ https://www.ncbi.nlm.nih.gov/pubmed/23291663 http://dx.doi.org/10.3892/or.2013.2221 |
Ejemplares similares
-
Current status of molecular-targeted drugs for endometrial cancer (Review)
por: NOGAMI, YUYA, et al.
Publicado: (2013) -
Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)
por: Umene, Kiyoko, et al.
Publicado: (2019) -
Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
por: Banno, Kouji, et al.
Publicado: (2013) -
Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
por: Banno, Kouji, et al.
Publicado: (2012) -
Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome
por: BANNO, KOUJI, et al.
Publicado: (2012)